H-KLVVGAVGV-OH

Ref. 3D-PP43599

Produktinformation

• Name: H-KLVVGAVGV-OH
• Synonyme: NH2-Lys-Leu-Val-Val-Gly-Ala-Val-Gly-Val-OH

Beschreibung

Peptide H-KLVVGAVGV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KLVVGAVGV-OH include the following: Neef es M Mishto - Urlaub, H., & , 2021 - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A3309039/download Confirmed identification of an HLA-A* 02: 01+ KRAS G12V+ cis-spliced peptide produced by proteasomes M Mishto , G Rodriguez-Hernandez, J Neefjes - kclpure.kcl.ac.ukhttps://kclpure.kcl.ac.uk/portal/files/160228538/main_text_Rebuttal_letter_Front_immunol_rev_v1.pdf Response: Commentary: An in silico-in vitro pipeline identifying an HLA-A* 02: 01+ KRAS G12V+ spliced epitope candidate for a broad tumor-immune M Mishto , G Rodriguez-Hernandez, J Neefjes - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.679836/full Commentary: An in silico-in vitro pipeline identifying an HLA-A* 02: 01+ KRAS G12V+ spliced epitope candidate for a broad tumor-immune response in I Beer - Frontiers in immunology, 2021 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.523906 In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G Willimsky, C Beier, L Immisch, G Papafotiou - Elife, 2021 - elifesciences.orghttps://elifesciences.org/articles/62019 TAPIR: a T-cell receptor language model for predicting rare and novel targets E Fast , M Dhar, B Chen - bioRxiv, 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515850/ Navigating critical challenges associated with immunopeptidomics-based detection of proteasomal spliced peptide candidates CF Lichti , N Vigneron, KR Clauser - Cancer immunology , 2022 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/10/3/275/681728

• Marke: Biosynth